TAVI: Late-Breaking Trials and Innovations

Session comprising selected PCR London Valves 2022 Late-Breaking Trial submissions

Anchorperson: C. Tamburino

Moderator: M. Reardon

Summary

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

Presentations available when logged in:

Early safety and performance of the Vienna TAVI system: first-in-man feasibility study results
Paravalvular leak and haemodynamics by valve size for the Navitor transcatheter aortic heart valve
DurAVR transcatheter aortic valve first-in-man study: impact of novel leaflet design
30-day results from the ACURATE neo2 post-market study
New-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI: Late-Breaking Trials and Innovations

Session comprising selected PCR London Valves 2022 Late-Breaking Trial submissions

Log in or create account for free